Outcomes and prognostic factors in nodular melanomas.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Surgery

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.surg.2012.07.006PMID 22925134
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.

  2012cited by this paper
• Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model

  2012cited by this paper
• Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi

  2011cited by this paper
• Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta‐analysis

  2011cited by this paper
• Factors Predicting Recurrence and Survival in Sentinel Lymph Node-Positive Melanoma Patients

  2011cited by this paper
• The Prognostic Significance of Nonsentinel Lymph Node Metastasis in Melanoma

  2010cited by this paper
• Predictors of sentinel lymph node metastasis in melanoma.

  2010cited by this paper
• Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma

  2010cited by this paper
• Prognostic Significance of a Positive Nonsentinel Lymph Node in Cutaneous Melanoma

  2009cited by this paper
• Final version of 2009 AJCC melanoma staging and classification.

  2009cited by this paper
• Changes in the presentation of nodular and superficial spreading melanomas over 35 years

  2008cited by this paper
• Positive Nonsentinel Node Status Predicts Mortality in Patients with Cutaneous Melanoma

  2008cited by this paper
• Final results of the Sunbelt Melanoma Trial

  2008cited by this paper
• Characteristics associated with early and late melanoma metastases

  2006cited by this paper
• Gender-Related Differences in Outcome for Melanoma Patients

  2006cited by this paper
• BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival.

  2005cited by this paper
• Early detection of thick melanomas in the United States: beware of the nodular subtype.

  2005cited by this paper
• Correlation Between Prognostic Factors and Increasing Age in Melanoma

  2004cited by this paper
• Lessons learned from the Sunbelt Melanoma Trial

  2004cited by this paper
• Invasive cutaneous malignant melanoma in Sweden, 1990–1999

  2004cited by this paper
• Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia.

  2002cited by this paper
• Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma.

  2001cited by this paper
• The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma

  2001cited by this paper
• Age as a prognostic factor in the malignant melanoma population

  1994cited by this paper
• The classification of malignant melanoma and its histologic reporting

  1973cited by this paper

• Diagnostic and prognostic risk factors analysis for distant metastasis in melanoma: a population-based study

  2024cites this paper
• Artificial intelligence-assisted metastasis and prognosis model for patients with nodular melanoma

  2024cites this paper
• Cutaneous melanoma survival rates of the elderly are not worse than those of the young, yet they have some specific differences

  2023cites this paper
• Prognostic factors for in-transit metastasis in patients with malignant melanoma

  2021cites this paper
• Not all melanomas are created equal: a review and call for more research into nodular melanoma

  2021cites this paper
• Clinicopathologic Features of Cutaneous Malignant Melanoma and Their Impact on Prognosis

  2020cites this paper
• Defining the prognostic role of microRNAs in cutaneous melanoma.

  2020cites this paper
• Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases

  2017cites this paper
• Diagnostic spectrum of nodular melanoma

  2016cites this paper
• Giant Centrifugal and Necrotizing Cutaneous Metastases of Melanoma

  2016cites this paper
• Presentation and Management of Inguinal Lymphadenopathy in Ovarian Cancer

  2016cites this paper
• Prognostic survival model for people diagnosed with invasive cutaneous melanoma

  2015cites this paper
• KLINIČNI PRIMER/CASE REPORT

  2015cites this paper
• Regional biologic characteristics of skin melanoma

  2015cites this paper
• Paediatric Dermatology Column: Case Report Paediatric melanoma: challenges in diagnosis and management

  2014cites this paper
• Paediatric melanoma : challenges in diagnosis and management

  2014cites this paper
• Surgical Pathology of Melanocytic Neoplasms

  2014cites this paper
• Analysis of clinical, dermoscopic and histopathological features of primary melanomas of patients with metastatic disease – a retrospective study at the Department of Dermatology, Medical University of Graz, 2000–2010

  2014cites this paper
• Outcomes and prognostic factors in superficial spreading melanoma.

  2013cites this paper
• The epidemiology of cutaneous melanoma in the Krasnodar region

  2013cites this paper